Soluble urokinase plasminogen activator receptor (suPAR) for the prediction of ventilator-associated pneumonia (VAP)
P. van Oort (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), P. Povoa (Lisbon, Portugal), P. Ramirez (Valencia, Spain), A. Torres (Madrid, Spain), A. Artigas (Madrid, Spain), M. Schultz (Amsterdam, Netherlands), I. Martin-Loeches (Madrid, Spain)
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Disease area: Respiratory critical care, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. van Oort (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), P. Povoa (Lisbon, Portugal), P. Ramirez (Valencia, Spain), A. Torres (Madrid, Spain), A. Artigas (Madrid, Spain), M. Schultz (Amsterdam, Netherlands), I. Martin-Loeches (Madrid, Spain). Soluble urokinase plasminogen activator receptor (suPAR) for the prediction of ventilator-associated pneumonia (VAP). 2607
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: